The NMDA Receptor NR2B Subunit: A Valid Therapeutic Target for Multiple CNS Pathologies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|3|389-396

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.3, 2004-02, pp. : 389-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze

By Guscott M.R.   Clarke H.F.   Murray F.   Grimwood S.   Bristow L.J.   Hutson P.H.  

European Journal of Pharmacology, Vol. 476, Iss. 3, 2003-08 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

NR2B Selective NMDA Receptor Antagonists

By  

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite

Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit

By Boyce-Rustay Janel   Holmes Andrew  

Psychopharmacology, Vol. 187, Iss. 4, 2006-09 ,pp. : 455-466

Springer Publishing Company

Access to resources Recommend Favorite

The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 169-179

Bentham Science Publishers

Access to resources Recommend Favorite

NMDA receptor antagonists as analgesics: focus on the NR2B subtype

By Chizh B.A.   Headley P.M.   Tzschentke T.M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite